Skip to main content
Health & Medicine

Toward a Healthier Future Through Obesity Prevention and Care: The JAMA Summit Report on Obesity.

| Source: JAMA

Obesity is one of the most difficult challenges of the modern era, affecting more than 1 billion people worldwide. Nearly half of US adults and 1 in 5 US children meet the medical definition of having obesity, with major consequences for cardiometabolic, kidney, hepatic, pulmonary, musculoskeletal, reproductive, oncologic, and mental health. Obesity also carries social and economic harms through stigma, discrimination, and bias. Drivers of the obesity epidemic include changes in food production

Obesity is one of the most difficult challenges of the modern era, affecting more than 1 billion people worldwide. Nearly half of US adults and 1 in 5 US children meet the medical definition of having obesity, with major consequences for cardiometabolic, kidney, hepatic, pulmonary, musculoskeletal, reproductive, oncologic, and mental health. Obesity also carries social and economic harms through stigma, discrimination, and bias. Drivers of the obesity epidemic include changes in food production and consumption accompanied by social, economic, and technological shifts that reduce food preparation, disrupt sleep, and decrease physical activity. The burden of these changes is not equally distributed, with higher obesity prevalence among socioeconomically disadvantaged populations. Current prevention measures include nutrition standards, food and menu labeling, school meal policies, sugar-sweetened beverage taxes, community-based lifestyle programs, and public assistance efforts. The impact of these approaches has been inadequate. Contemporary clinical management recognizes obesity as a chronic disease characterized by genetic, biological, and behavioral susceptibilities. Access, affordability, tolerability, and the chronicity of use remain major challenges for all available obesity management strategies, including new glucagon-like peptide-1 receptor agonist therapies. Potential solutions require a coordinated, multisector response and include efforts to prevent obesity at the societal level, improve care of individuals with obesity, and strengthen research and innovation. Priority areas include improving the food and physical activity environment; strengthening communication and education; strengthening childhood obesity prevention; addressing health inequities; reducing stigma and bias; modernizing obesity care delivery; expanding access to lifestyle, healthy food, medication, and surgical interventions; and supporting long-term treatment adherence and maintenance. Proposed actions include new government policies on food production, labeling, marketing, and school nutrition; modernization of drug evaluation; payment reform to support comprehensive obesity treatment; development of multidisciplinary care models; incentives to promote cross-sector partnerships; and research to advance personalized prevention and treatment strategies. The emergence of effective obesity management medications offers a significant opportunity to curb the prevalence of obesity. However, no single intervention will be enough. Sustained improvement will require addressing the underlying structural and environmental drivers of obesity, along with person-centered, multilevel strategies that simultaneously improve prevention, reduce stigma, and expand equitable access to evidence-based treatment. Coordinated action across government, health care systems, clinicians, payers, industry, schools, communities, and researchers will be essential to achieving long-term improvement.

Read the original source →

Related Stories

Health & Medicine

Distinct nanoscale architectures of GABAergic inhibitory synapses predict diverse synaptic output.

GABAergic synaptic inhibition is heterogenous across neuronal compartments, and plays a critical role in shaping local, cellular, and circuit excitability. In pyramidal neurons, inhibition is mediated by GABA A receptors (GABA A Rs) clustered at the inhibitory postsynaptic domain (iPSD). Synaptic strength depends not only on the number of GABA A Rs within the iPSD, but also on their precise nanoscale organization into discrete subsynaptic domains (SSDs). These SSDs often align with presynaptic G

Continue reading
Health & Medicine

Leptin Receptor + cells create a perisinusoidal niche for thrombopoiesis in the bone marrow by synthesizing CXCL14.

Leptin Receptor-expressing (LepR + ) stromal cells in the bone marrow are a critical source of growth factors for the maintenance of hematopoietic stem cells (HSCs) and most restricted hematopoietic progenitors. An important unresolved question is whether they also regulate terminal differentiation in some hematopoietic cells. We found that bone marrow LepR + cells promote thrombopoiesis by synthesizing the chemokine CXCL14. Cxcl14 -expressing LepR + cells extend fine processes that wrap around

Continue reading
Health & Medicine

Homeostatic control of stem cell activity during intestinal regeneration.

Stem cells proliferate rapidly to maintain tissue turnover during regeneration, yet the mechanisms preventing hyperproliferation remain unclear. Here, we identified nuclear factor Y (NF-Y) as a transcriptional repressor that maintains intestinal stem cell (ISC) quiescence. NF-Y restricts ISC proliferation by occupying the promoters of epidermal growth factor receptor (EGFR) signaling components, including Egfr , Mkp3 , Raf , Ras , and pnt , through regulation dependent on the histone acetyltrans

Continue reading
Health & Medicine

Spatial transcriptomics reveals organizational properties of the mouse spinal cord and alterations in neuropathic pain.

The spinal cord integrates diverse somatosensory inputs and executes motor outputs through anatomically and functionally distinct circuits. Here, we employed spatially resolved single-cell transcriptomic profiling of the adult mouse spinal cord to gain insights into the organizational logic of the spinal cord. Our results reveal distinct spatial and laminar distributions of neuronal subtypes, including axial level and sex-specific differences. Many neuronal subtypes exhibit lamina-specific somat

Continue reading
Health & Medicine

Acute degradation of Pumilio proteins reveals a biphasic posttranscriptional regulatory hierarchy in embryonic stem cell fate decision.

Posttranscriptional regulation is critical for mammalian embryogenesis yet has been underexplored. We previously showed that RNA-binding Pumilio proteins (Pum1/2) are essential for early mouse embryogenesis and embryonic stem cell (ESC) functions. Here, using acute protein degradation systems combined with time-resolved RNA sequencing and enhanced crosslinking and immunoprecipitation, we delineate a two-phase regulatory hierarchy modulated by Pum1/2 in mouse ESCs. The first phase, occurring with

Continue reading